Acinetobacter baumannii bacteraemia in Hong Kong

Journal of Hospital Infection

Volumn 75, Issue 1, 2010, Pages 81-

  You, J H S ^a   Chow, T C P ^a   Yeung, A W C ^a   Lee, N ^b   Ip, M ^a  

^a Chinese University of Hong Kong   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGE; ARTIFICIAL VENTILATION; BACTEREMIA; BLOOD CULTURE; COMORBIDITY; CONGESTIVE HEART FAILURE; DRUG TREATMENT FAILURE; FEMALE; HEALTH CARE COST; HONG KONG; HUMAN; INTENSIVE CARE; INTRAVENOUS CATHETER; LENGTH OF STAY; LETTER; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; RELAPSE; SEPSIS; WOUND INFECTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; HEALTH CARE COSTS; HONG KONG; HUMANS; MALE; MIDDLE AGED; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 77951298324     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.12.002     Document Type: Letter

References (3)

1. Kuo L.C., Lai C.C., Liao C.H., et al. Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome. Clin Microbiol Infect 2007, 13:196-198.
2. Lee N.Y., Lee H.C., Ko N.Y., et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007, 28:713-719.
3. Siau H., Yuen K.Y., Ho P.L., Wong S.S., Woo P.C. Acinetobacter bacteremia in Hong Kong: prospective study and review. Clin Infect Dis 1999, 28:26-30.